skip to main content

H.R. 3797 (116th): Medical Marijuana Research Act


The text of the bill below is as of Dec 4, 2020 (Preprint (Suspension)).


G:\M\16\SUSPENSION\H3797_SUS.XML




                                Suspend the Rules and Pass the Bill, H.R. 3797, with an Amendment

                                 (The amendment strikes all after the enacting clause and inserts a
                                                            new text)

                               116TH CONGRESS
                                  2D SESSION
                                                                    H. R. 3797
                               To amend the Controlled Substances Act to make marijuana accessible for
                                   use by qualified marijuana researchers for medical purposes, and for
                                   other purposes.




                                             IN THE HOUSE OF REPRESENTATIVES
                                                                JULY 17, 2019
                               Mr. BLUMENAUER (for himself, Mr. HARRIS, Ms. LOFGREN, Mr. GRIFFITH,
                                   Mr. BISHOP of Utah, and Mrs. DINGELL) introduced the following bill;
                                   which was referred to the Committee on Energy and Commerce, and in
                                   addition to the Committee on the Judiciary, for a period to be subse-
                                   quently determined by the Speaker, in each case for consideration of such
                                   provisions as fall within the jurisdiction of the committee concerned




                                                                         A BILL
                               To amend the Controlled Substances Act to make marijuana
                                  accessible for use by qualified marijuana researchers for
                                  medical purposes, and for other purposes.

                                 1              Be it enacted by the Senate and House of Representa-
                                 2 tives of the United States of America in Congress assembled,
                                 3     SECTION 1. SHORT TITLE.

                                 4              This Act may be cited as the ‘‘Medical Marijuana Re-
                                 5 search Act’’.

           n/a     (778095|13)
           December 8, 2020 (10:55 a.m.)
VerDate Mar 15 2010   10:55 Dec 08, 2020   Jkt 000000   PO 00000   Frm 00001   Fmt 6652   Sfmt 6201   C:\USERS\WPBURKE\APPDATA\ROAMING\SOFTQUAD\XMETAL\7.0\GEN\C\H3797_SUS

G:\M\16\SUSPENSION\H3797_SUS.XML 2 1 SEC. 2. FACILITATING MARIJUANA RESEARCH. 2 (a) PRODUCTION AND SUPPLY.—The Secretary of 3 Health and Human Services— 4 (1) until the date on which the Secretary deter- 5 mines that manufacturers and distributors (other 6 than the Federal Government) can ensure a suffi- 7 cient supply of marijuana (as defined in section 102 8 of the Controlled Substances Act (21 U.S.C. 802), 9 as amended by section 8) intended for research by 10 qualified marijuana researchers registered pursuant 11 to paragraph (3) of section 303(f) of the Controlled 12 Substances Act (21 U.S.C. 823(f)), as added by sec- 13 tion 3, shall— 14 (A) continue, through grants, contracts, or 15 cooperative agreements, to produce marijuana 16 through the National Institute on Drug Abuse 17 Drug Supply Program; 18 (B) not later than one year after the date 19 of enactment of this Act, act jointly with the 20 Attorney General of the United States to estab- 21 lish and implement a specialized process for 22 manufacturers and distributors, notwith- 23 standing the registration requirements of sec- 24 tion 303 of such Act (21 U.S.C. 823), to supply 25 qualified marijuana researchers with marijuana 26 products— n/a (778095|13) December 8, 2020 (10:55 a.m.) VerDate Mar 15 2010 10:55 Dec 08, 2020 Jkt 000000 PO 00000 Frm 00002 Fmt 6652 Sfmt 6201 C:\USERS\WPBURKE\APPDATA\ROAMING\SOFTQUAD\XMETAL\7.0\GEN\C\H3797_SUS
G:\M\16\SUSPENSION\H3797_SUS.XML 3 1 (i) available through State-authorized 2 marijuana programs; and 3 (ii) consistent with the guidance 4 issued under subsection (c); and 5 (C) not later than 60 days after the date 6 of enactment of this Act, jointly convene with 7 the Attorney General a meeting to initiate the 8 development of the specialized process described 9 in subparagraph (B); and 10 (2) beyond the date specified in paragraph (1), 11 may, at the Secretary’s discretion, continue— 12 (A) through grants, contracts, or coopera- 13 tive agreements, to so produce marijuana; and 14 (B) to implement such specialized process. 15 (b) REQUIREMENT TO VERIFY REGISTRATION.—Be- 16 fore supplying marijuana to any person through the Na- 17 tional Institute on Drug Abuse Drug Supply Program or 18 through implementation of the specialized process estab- 19 lished under subsection (a)(1)(B), the Secretary of Health 20 and Human Services shall— 21 (1) require the person to submit documentation 22 demonstrating that the person is a qualified mari- 23 juana researcher seeking to conduct research pursu- 24 ant to section 303(f)(3) of the Controlled Substances 25 Act, as added by subsection (d) of this section, or n/a (778095|13) December 8, 2020 (10:55 a.m.) VerDate Mar 15 2010 10:55 Dec 08, 2020 Jkt 000000 PO 00000 Frm 00003 Fmt 6652 Sfmt 6201 C:\USERS\WPBURKE\APPDATA\ROAMING\SOFTQUAD\XMETAL\7.0\GEN\C\H3797_SUS
G:\M\16\SUSPENSION\H3797_SUS.XML 4 1 a manufacturer duly registered under section 303(l) 2 of the Controlled Substances Act, as added by sec- 3 tion 3 of this Act; and 4 (2) not later than 60 days after receipt of such 5 documentation, review such documentation and 6 verify that the marijuana will be used for such re- 7 search (and for no other purpose authorized pursu- 8 ant to this Act or the amendments made by this 9 Act). 10 (c) GUIDANCE ON USE OF STATE-AUTHORIZED 11 MARIJUANA PROGRAMS.—Not later than 180 days after 12 the date of the enactment of this Act, the Secretary of 13 Health and Human Services shall issue guidance related 14 to marijuana from State-authorized marijuana programs 15 for research. 16 (d) RESEARCH.—Section 303(f) of the Controlled 17 Substances Act (21 U.S.C. 823(f)) is amended— 18 (1) by redesignating paragraphs (1) through 19 (5) as subparagraphs (A) through (E), respectively; 20 (2) by striking ‘‘(f) The Attorney General’’ and 21 inserting ‘‘(f)(1) The Attorney General’’; 22 (3) by striking ‘‘Registration applications’’ and 23 inserting the following: 24 ‘‘(2) Registration applications’’; n/a (778095|13) December 8, 2020 (10:55 a.m.) VerDate Mar 15 2010 10:55 Dec 08, 2020 Jkt 000000 PO 00000 Frm 00004 Fmt 6652 Sfmt 6201 C:\USERS\WPBURKE\APPDATA\ROAMING\SOFTQUAD\XMETAL\7.0\GEN\C\H3797_SUS
G:\M\16\SUSPENSION\H3797_SUS.XML 5 1 (4) in paragraph (2), as so designated, by strik- 2 ing ‘‘schedule I’’ each place that term appears and 3 inserting ‘‘schedule I, except marijuana,’’; 4 (5) by striking ‘‘Article 7’’ and inserting the 5 following: 6 ‘‘(4) Article 7’’; and 7 (6) by inserting before paragraph (4), as so 8 designated, the following: 9 ‘‘(3)(A) The Attorney General shall register the ap- 10 plicant to conduct research with marijuana if— 11 ‘‘(i) the applicant is authorized to dispense, or 12 conduct research with respect to, controlled sub- 13 stances in schedule I, II, III, IV, or V; 14 ‘‘(ii) the applicant is compliant with, and au- 15 thorized to conduct the activities described in clause 16 (i) under, the laws of the State in which the appli- 17 cant practices; and 18 ‘‘(iii) in the case of an applicant pursuing clin- 19 ical research, the applicant’s clinical research pro- 20 tocol has been reviewed and authorized to proceed by 21 the Secretary under section 505(i) of the Federal 22 Food, Drug, and Cosmetic Act. 23 ‘‘(B) An applicant registered under subparagraph (A) 24 shall be referred to in this section as a ‘qualified mari- 25 juana researcher’. n/a (778095|13) December 8, 2020 (10:55 a.m.) VerDate Mar 15 2010 10:55 Dec 08, 2020 Jkt 000000 PO 00000 Frm 00005 Fmt 6652 Sfmt 6201 C:\USERS\WPBURKE\APPDATA\ROAMING\SOFTQUAD\XMETAL\7.0\GEN\C\H3797_SUS
G:\M\16\SUSPENSION\H3797_SUS.XML 6 1 ‘‘(C)(i) Not later than 60 days after the date on 2 which the Attorney General receives a complete applica- 3 tion for registration under this paragraph, the Attorney 4 General shall approve or deny the application. 5 ‘‘(ii) For purposes of clause (i), an application shall 6 be deemed complete when the applicant has submitted 7 documentation showing that the requirements under sub- 8 paragraph (A) are satisfied. 9 ‘‘(iii) In the case of a denial under clause (i), the At- 10 torney General shall provide a written explanation of the 11 basis for the denial. 12 ‘‘(D) The Attorney General shall grant an application 13 for registration under this paragraph unless the Attorney 14 General determines that the issuance of the registration 15 would be inconsistent with the public interest. In deter- 16 mining the public interest, the following factors shall be 17 considered: 18 ‘‘(i) The applicant’s experience in dispensing, or 19 conducting research with respect to, controlled sub- 20 stances. 21 ‘‘(ii) The applicant’s conviction record under 22 Federal or State laws relating to the manufacture, 23 distribution, or dispensing of controlled substances. n/a (778095|13) December 8, 2020 (10:55 a.m.) VerDate Mar 15 2010 10:55 Dec 08, 2020 Jkt 000000 PO 00000 Frm 00006 Fmt 6652 Sfmt 6201 C:\USERS\WPBURKE\APPDATA\ROAMING\SOFTQUAD\XMETAL\7.0\GEN\C\H3797_SUS
G:\M\16\SUSPENSION\H3797_SUS.XML 7 1 ‘‘(iii) Compliance with applicable State or local 2 laws relating to controlled substance misuse or diver- 3 sion. 4 ‘‘(iv) Such other conduct which may threaten 5 the public health and safety. 6 ‘‘(E)(i) A qualified marijuana researcher shall store 7 marijuana to be used in research in a securely locked, sub- 8 stantially constructed cabinet. 9 ‘‘(ii) Except as provided in clause (i), any security 10 measures required by the Attorney General for applicants 11 conducting research with marijuana pursuant to a reg- 12 istration under this paragraph shall be consistent with the 13 security measures for applicants conducting research on 14 other controlled substances in schedule II that have a 15 similar risk of diversion and abuse. 16 ‘‘(F)(i) If the Attorney General grants an application 17 for registration under this paragraph, the applicant may 18 amend or supplement the research protocol and proceed 19 with the research under such amended or supplemented 20 protocol, without additional review or approval by the At- 21 torney General or the Secretary of Health and Human 22 Services if the applicant does not change the type of mari- 23 juana, the source of the marijuana, or the conditions 24 under which the marijuana is stored, tracked, or adminis- 25 tered. n/a (778095|13) December 8, 2020 (10:55 a.m.) VerDate Mar 15 2010 10:55 Dec 08, 2020 Jkt 000000 PO 00000 Frm 00007 Fmt 6652 Sfmt 6201 C:\USERS\WPBURKE\APPDATA\ROAMING\SOFTQUAD\XMETAL\7.0\GEN\C\H3797_SUS
G:\M\16\SUSPENSION\H3797_SUS.XML 8 1 ‘‘(ii) If an applicant amends or supplements the re- 2 search protocol or initiates research on a new research 3 protocol under clause (i), the applicant shall, in order to 4 renew the registration under this paragraph, provide no- 5 tice to the Attorney General of the amended or supple- 6 mented research protocol or any new research protocol in 7 the applicant’s renewal materials. 8 ‘‘(iii)(I) If an applicant amends or supplements a re- 9 search protocol and the amendment or supplement in- 10 volves a change to the type of marijuana, the source of 11 the marijuana, or conditions under which the marijuana 12 is stored, tracked, or administered, the applicant shall pro- 13 vide notice to the Attorney General not later than 30 days 14 before proceeding on such amended or supplemental re- 15 search or new research protocol, as the case may be. 16 ‘‘(II) If the Attorney General does not object during 17 the 30-day period following a notification under subclause 18 (I), the applicant may proceed with the amended or sup- 19 plemental research or new research protocol. 20 ‘‘(iv) The Attorney General may object to an amend- 21 ed or supplemental protocol or a new research protocol 22 under clause (i) or (iii) only if additional security meas- 23 ures are needed to safeguard against diversion or abuse. 24 ‘‘(G) If marijuana is listed on a schedule other than 25 schedule I, the provisions of paragraphs (1), (2), and (4) n/a (778095|13) December 8, 2020 (10:55 a.m.) VerDate Mar 15 2010 10:55 Dec 08, 2020 Jkt 000000 PO 00000 Frm 00008 Fmt 6652 Sfmt 6201 C:\USERS\WPBURKE\APPDATA\ROAMING\SOFTQUAD\XMETAL\7.0\GEN\C\H3797_SUS
G:\M\16\SUSPENSION\H3797_SUS.XML 9 1 that apply to research with a controlled substance in the 2 applicable schedule shall apply to research with marijuana 3 or that compound, as applicable, in lieu of the provisions 4 of subparagraphs (A) through (F) of this paragraph. 5 ‘‘(H) Nothing in this paragraph shall be construed 6 as limiting the authority of the Secretary under section 7 505(i) of the Federal Food, Drug, and Cosmetic Act or 8 over requirements related to research protocols, including 9 changes in— 10 ‘‘(i) the method of administration of marijuana; 11 ‘‘(ii) the dosing of marijuana; and 12 ‘‘(iii) the number of individuals or patients in- 13 volved in research.’’. 14 SEC. 3. MANUFACTURE AND DISTRIBUTION OF MARIJUANA 15 FOR USE IN LEGITIMATE RESEARCH. 16 Section 303 of the Controlled Substances Act (21 17 U.S.C. 823), as amended by section 2, is further amended 18 by adding at the end the following: 19 ‘‘(l) REGISTRATION OF PERSONS TO MANUFACTURE 20 AND DISTRIBUTE MARIJUANA FOR USE IN LEGITIMATE 21 RESEARCH.— 22 ‘‘(1) REGISTRATION OF MANUFACTURERS.— 23 ‘‘(A) IN GENERAL.—Beginning not later 24 than the day that is 1 year after the date of en- 25 actment of the Medical Marijuana Research n/a (778095|13) December 8, 2020 (10:55 a.m.) VerDate Mar 15 2010 10:55 Dec 08, 2020 Jkt 000000 PO 00000 Frm 00009 Fmt 6652 Sfmt 6201 C:\USERS\WPBURKE\APPDATA\ROAMING\SOFTQUAD\XMETAL\7.0\GEN\C\H3797_SUS
G:\M\16\SUSPENSION\H3797_SUS.XML 10 1 Act, the Attorney General, pursuant to sub- 2 section (f)(3) and subject to subparagraph (B) 3 of this paragraph, shall register an applicant to 4 manufacture marijuana (including any deriva- 5 tive, extract, preparation, and compound there- 6 of) that is intended for— 7 ‘‘(i) the ultimate and exclusive use by 8 qualified marijuana researchers for re- 9 search pursuant to subsection (f)(3); or 10 ‘‘(ii) subsequent downstream manu- 11 facture by a duly registered manufacturer 12 for the ultimate and exclusive use by quali- 13 fied marijuana researchers for research 14 pursuant to subsection (f)(3). 15 ‘‘(B) PUBLIC INTEREST.—The Attorney 16 General shall register an applicant under sub- 17 paragraph (A) unless the Attorney General de- 18 termines that the issuance of such registration 19 is inconsistent with the public interest. In deter- 20 mining the public interest, the Attorney General 21 shall take into consideration— 22 ‘‘(i) maintenance of effective controls 23 against diversion of marijuana and any 24 controlled substance compounded there- n/a (778095|13) December 8, 2020 (10:55 a.m.) VerDate Mar 15 2010 10:55 Dec 08, 2020 Jkt 000000 PO 00000 Frm 00010 Fmt 6652 Sfmt 6201 C:\USERS\WPBURKE\APPDATA\ROAMING\SOFTQUAD\XMETAL\7.0\GEN\C\H3797_SUS
G:\M\16\SUSPENSION\H3797_SUS.XML 11 1 from into other than legitimate medical, 2 scientific, or research channels; 3 ‘‘(ii) compliance with applicable State 4 and local laws relating to controlled sub- 5 stance misuse and diversion; 6 ‘‘(iii) prior conviction record of the 7 applicant under Federal or State laws re- 8 lating to the manufacture, distribution, or 9 dispensing of such substances; and 10 ‘‘(iv) such other conduct which may 11 threaten the public health and safety. 12 ‘‘(2) REGISTRATION OF DISTRIBUTORS.— 13 ‘‘(A) IN GENERAL.—Beginning not later 14 than the day that is 1 year after the date of en- 15 actment of the Medical Marijuana Research 16 Act, the Attorney General shall register an ap- 17 plicant to distribute marijuana (including any 18 derivative, extract, preparation, and compound 19 thereof) that is intended for the ultimate and 20 exclusive use by qualified marijuana researchers 21 for research pursuant to subsection (f)(3) or in- 22 tended for subsequent downstream manufacture 23 by a duly registered manufacturer for use by 24 qualified marijuana researchers for research 25 pursuant to such subsection, unless the Attor- n/a (778095|13) December 8, 2020 (10:55 a.m.) VerDate Mar 15 2010 10:55 Dec 08, 2020 Jkt 000000 PO 00000 Frm 00011 Fmt 6652 Sfmt 6201 C:\USERS\WPBURKE\APPDATA\ROAMING\SOFTQUAD\XMETAL\7.0\GEN\C\H3797_SUS
G:\M\16\SUSPENSION\H3797_SUS.XML 12 1 ney General determines that the issuance of 2 such registration is inconsistent with the public 3 interest. 4 ‘‘(B) PUBLIC INTEREST.—In determining 5 the public interest under subparagraph (A), the 6 Attorney General shall take into consider- 7 ation— 8 ‘‘(i) the factors specified in clauses (i), 9 (ii), (iii), and (iv) of paragraph (1)(B); and 10 ‘‘(ii) past experience in the distribu- 11 tion of controlled substances, and the exist- 12 ence of effective controls against diversion. 13 ‘‘(3) NO LIMIT ON NUMBER OF MANUFACTUR- 14 ERS AND DISTRIBUTORS.—Notwithstanding any 15 other provision of law, the Attorney General shall 16 not impose or implement any limit on the number of 17 persons eligible to be registered to manufacture or 18 distribute marijuana pursuant to paragraph (1) or 19 (2). 20 ‘‘(4) REQUIREMENT TO VERIFY USE FOR LE- 21 GITIMATE RESEARCH.—As a condition of registra- 22 tion under this section to manufacture or distribute 23 marijuana, the Attorney General shall require the 24 registrant— n/a (778095|13) December 8, 2020 (10:55 a.m.) VerDate Mar 15 2010 10:55 Dec 08, 2020 Jkt 000000 PO 00000 Frm 00012 Fmt 6652 Sfmt 6201 C:\USERS\WPBURKE\APPDATA\ROAMING\SOFTQUAD\XMETAL\7.0\GEN\C\H3797_SUS
G:\M\16\SUSPENSION\H3797_SUS.XML 13 1 ‘‘(A) to require any person to whom the 2 marijuana will be supplied to submit docu- 3 mentation demonstrating that the marijuana 4 (including any derivative, extract, preparation, 5 and compound thereof) will be ultimately used 6 exclusively by qualified marijuana researchers 7 for research pursuant to subsection (f)(3) or for 8 subsequent downstream manufacture by a duly 9 registered manufacturer for use by qualified 10 marijuana researchers for research pursuant to 11 such subsection; 12 ‘‘(B) in the case of distribution, to com- 13 plete, with respect to that distribution, the ap- 14 propriate order form in accordance with section 15 308 and to upload such forms to the system 16 used by the Drug Enforcement Administration 17 for such distribution; 18 ‘‘(C) to include in the labeling of any mari- 19 juana so manufactured or distributed— 20 ‘‘(i) the following statement: ‘This 21 material is for biomedical and scientific re- 22 search purposes only.’; and 23 ‘‘(ii) the name of the requestor of the 24 marijuana; n/a (778095|13) December 8, 2020 (10:55 a.m.) VerDate Mar 15 2010 10:55 Dec 08, 2020 Jkt 000000 PO 00000 Frm 00013 Fmt 6652 Sfmt 6201 C:\USERS\WPBURKE\APPDATA\ROAMING\SOFTQUAD\XMETAL\7.0\GEN\C\H3797_SUS
G:\M\16\SUSPENSION\H3797_SUS.XML 14 1 ‘‘(D) to limit the transfer and sale of any 2 marijuana under this subsection— 3 ‘‘(i) to researchers who are registered 4 under this Act to conduct research with 5 marijuana or to manufacturers duly reg- 6 istered under this subsection; and 7 ‘‘(ii) for purposes of use in preclinical 8 research or in a clinical investigation pur- 9 suant to an investigational new drug ex- 10 emption under 505(i) of the Federal Food, 11 Drug, and Cosmetic Act or for the pur- 12 poses of further manufacturing of mari- 13 juana; and 14 ‘‘(E) to transfer or sell any marijuana 15 manufactured under this subsection only with 16 prior, written consent for the transfer or sale by 17 the Attorney General. 18 ‘‘(5) TIMING.—Not later than 60 days after re- 19 ceipt of a request for registration under this sub- 20 section to manufacture or distribute marijuana, the 21 Attorney General shall— 22 ‘‘(A) grant or deny the request; and 23 ‘‘(B) in the case of a denial, provide a 24 written explanation of the basis for the denial. n/a (778095|13) December 8, 2020 (10:55 a.m.) VerDate Mar 15 2010 10:55 Dec 08, 2020 Jkt 000000 PO 00000 Frm 00014 Fmt 6652 Sfmt 6201 C:\USERS\WPBURKE\APPDATA\ROAMING\SOFTQUAD\XMETAL\7.0\GEN\C\H3797_SUS
G:\M\16\SUSPENSION\H3797_SUS.XML 15 1 ‘‘(6) DEEMED APPROVAL.—If the Attorney 2 General fails to grant or deny a request for registra- 3 tion under this subsection to manufacture or dis- 4 tribute marijuana within the 60-day period referred 5 to in paragraph (5), such request is deemed ap- 6 proved.’’. 7 SEC. 4. TERMINATION OF INTERDISCIPLINARY REVIEW 8 PROCESS FOR NON-NIH-FUNDED QUALIFIED 9 MARIJUANA RESEARCHERS. 10 The Secretary of Health and Human Services may 11 not— 12 (1) reinstate the Public Health Service inter- 13 disciplinary review process described in the guidance 14 entitled ‘‘Guidance on Procedures for the Provision 15 of Marijuana for Medical Research’’ (issued on May 16 21, 1999); or 17 (2) create an additional review of scientific pro- 18 tocols that is only conducted for research on mari- 19 juana other than the review of research protocols 20 performed at the request of a qualified marijuana 21 researcher conducting nonhuman research that is 22 not federally funded, in accordance with section 23 303(f)(3)(A) of the Controlled Substances Act, as 24 added by section 2 of this Act. n/a (778095|13) December 8, 2020 (10:55 a.m.) VerDate Mar 15 2010 10:55 Dec 08, 2020 Jkt 000000 PO 00000 Frm 00015 Fmt 6652 Sfmt 6201 C:\USERS\WPBURKE\APPDATA\ROAMING\SOFTQUAD\XMETAL\7.0\GEN\C\H3797_SUS
G:\M\16\SUSPENSION\H3797_SUS.XML 16 1 SEC. 5. CONSIDERATION OF RESULTS OF RESEARCH. 2 Immediately upon the approval by the Food and 3 Drug Administration of an application for a drug that 4 contains marijuana (as defined in section 102 of the Con- 5 trolled Substances Act (21 U.S.C. 802), as amended by 6 section 8 of this Act) under section 505 of the Federal 7 Food, Drug, and Cosmetic Act (21 U.S.C. 355), and (irre- 8 spective of whether any such approval is granted) not later 9 than the date that is 5 years after the date of enactment 10 of this Act, the Secretary of Health and Human Services 11 shall— 12 (1) conduct a review of existing medical and 13 other research with respect to marijuana; 14 (2) submit a report to the Congress on the re- 15 sults of such review; and 16 (3) include in such report whether, taking into 17 consideration the factors listed in section 201(c) of 18 the Controlled Substances Act (21 U.S.C. 811(c)), 19 as well as any potential for medical benefits, any 20 gaps in research, and any impacts of Federal restric- 21 tions and policy on research, marijuana should be 22 transferred to a schedule other than schedule I (if 23 marijuana has not been so transferred already). n/a (778095|13) December 8, 2020 (10:55 a.m.) VerDate Mar 15 2010 10:55 Dec 08, 2020 Jkt 000000 PO 00000 Frm 00016 Fmt 6652 Sfmt 6201 C:\USERS\WPBURKE\APPDATA\ROAMING\SOFTQUAD\XMETAL\7.0\GEN\C\H3797_SUS
G:\M\16\SUSPENSION\H3797_SUS.XML 17 1 SEC. 6. PRODUCTION QUOTAS FOR MARIJUANA GROWN 2 FOR LEGITIMATE, SCIENTIFIC RESEARCH. 3 Section 306 of the Controlled Substances Act (21 4 U.S.C. 826) is amended by adding at the end the fol- 5 lowing: 6 ‘‘(j) The Attorney General may only establish a quota 7 for production of marijuana that is manufactured and dis- 8 tributed in accordance with the Medical Marijuana Re- 9 search Act that meets the changing medical, scientific, and 10 industrial needs for marijuana.’’. 11 SEC. 7. ARTICLE 28 OF THE SINGLE CONVENTION ON NAR- 12 COTIC DRUGS. 13 Article 28 of the Single Convention on Narcotic 14 Drugs shall not be construed to prohibit, or impose addi- 15 tional restrictions upon, research involving marijuana, or 16 the manufacture, distribution, or dispensing of marijuana, 17 that is conducted in accordance with the Controlled Sub- 18 stances Act (21 U.S.C. 801 et seq.), this Act, and the 19 amendments made by this Act. 20 SEC. 8. DEFINITIONS. 21 (a) QUALIFIED MARIJUANA RESEARCHER.—In this 22 Act, the term ‘‘qualified marijuana researcher’’ has the 23 meaning given the term in section 303(f)(3) of the Con- 24 trolled Substances Act, as added by section 2(d) of this 25 Act. n/a (778095|13) December 8, 2020 (10:55 a.m.) VerDate Mar 15 2010 10:55 Dec 08, 2020 Jkt 000000 PO 00000 Frm 00017 Fmt 6652 Sfmt 6201 C:\USERS\WPBURKE\APPDATA\ROAMING\SOFTQUAD\XMETAL\7.0\GEN\C\H3797_SUS
G:\M\16\SUSPENSION\H3797_SUS.XML 18 1 (b) UPDATING TERM.—Section 102(16) of the Con- 2 trolled Substances Act (21 U.S.C. 802(16)) is amended— 3 (1) in subparagraph (A), by striking ‘‘the term 4 ‘marihuana’ means’’ and inserting ‘‘the terms ‘mari- 5 huana’ and ‘marijuana’ mean’’; and 6 (2) in subparagraph (B), by striking ‘‘The term 7 ‘marihuana’ does not’’ and inserting ‘‘The terms 8 ‘marihuana’ and ‘marijuana’ do not’’. 9 SEC. 9. DETERMINATION OF BUDGETARY EFFECTS. 10 The budgetary effects of this Act, for the purpose of 11 complying with the Statutory Pay-As-You-Go Act of 2010, 12 shall be determined by reference to the latest statement 13 titled ‘‘Budgetary Effects of PAYGO Legislation’’ for this 14 Act, submitted for printing in the Congressional Record 15 by the Chairman of the House Budget Committee, pro- 16 vided that such statement has been submitted prior to the 17 vote on passage. n/a (778095|13) December 8, 2020 (10:55 a.m.) VerDate Mar 15 2010 10:55 Dec 08, 2020 Jkt 000000 PO 00000 Frm 00018 Fmt 6652 Sfmt 6201 C:\USERS\WPBURKE\APPDATA\ROAMING\SOFTQUAD\XMETAL\7.0\GEN\C\H3797_SUS